![Seiji Okada Seiji Okada](https://s3.amazonaws.com/peerj_prod_upload/images/profile/s%2Fe%2FlyUswPkKBdhamCaPPQcBgg%3D%3D%2Fi200_62d2801d80abd2.78392851.jpeg)
PeerJ Author
370 Points
Contributions by role
Contributions by subject area
Seiji Okada
PeerJ Author
Summary
Seiji Okada M.D., Ph.D. is a Professor at the Joint Research Center for Human Retrovirus Infection & Graduate School of Medicine, and Director of Radioisotope Center, Kumamoto University, Japan. He received his M.D. in 1985 and his Ph.D. in 1992 from Jichi Medical University. He is a Board Certificated Member and Councilor of the Japanese Society of Hematology. He established several types of novel highly immuno-deficient mice, humanized mice, and Patient-derived tumor xenograft (PDX) models for AIDS and cancer research. His current research interest is developing novel therapy for infection-related cancers such as AIDS-related lymphoma, adult T-cell leukemia/lymphoma, and liver-fluke-related cholangiocarcinoma.
Past or current institution affiliations
Work details
Professor
Kumamoto University
Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection
PeerJ Contributions
March 2, 2023
Paksiree Saranaruk, Sakda Waraasawapati, Yaovalux Chamgramol, Kanlayanee Sawanyawisuth, Natnicha Paungpan, Narumon Somphud, Chaisiri Wongkham, Seiji Okada, Sopit Wongkham, Kulthida Vaeteewoottacharn
November 14, 2022
Kamonnaree Chotinantakul, Pattranuch Chusri, Seiji Okada
March 17, 2021
Prin Sungwan, Worachart Lert-itthiporn, Atit Silsirivanit, Nathakan Klinhom-on, Seiji Okada, Sopit Wongkham, Wunchana Seubwai